Type 1 T helper cells promote anti-tumor immunity through IFN-γ secretion and function as biomarkers for assessing inflammatory microenvironments, whereas Th17 cells exhibit a dual role in colorectal cancer, with their ratio serving as a potential biomarker for guiding IL-17 axis-targeted therapies [60]. This evidence concerns the gene IFNG and colorectal cancer.